Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Labeling changes for Seldane products

Sep. 25, 1997

Yamanouchi develops potent and selective PDE IV inhibitors

Sep. 25, 1997

Anti-IgE MAb progresses to late-stage clinical trials in asthma

Sep. 24, 1997

Duramycin available for licensing from MoliChem Medicines

Sep. 24, 1997

Novel leukotriene antagonists from Menarini

Sep. 22, 1997

Safer glucocorticoids for inflammatory/allergic disorders

Sep. 22, 1997

Glaxo Wellcome develops glucocorticoids with favorable side effect profile

Sep. 19, 1997

Transdermal lidocaine patch enters phase II/III for allergic rhinitis

Sep. 17, 1997

First U.S. clinical trial of pranlukast

Sep. 17, 1997

Takeda reports MIP-1alpha/RANTES receptor antagonists

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...